Vise Technologies Inc. Buys 2,256 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vise Technologies Inc. boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 84.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,925 shares of the medical equipment provider's stock after purchasing an additional 2,256 shares during the quarter. Vise Technologies Inc.'s holdings in Intuitive Surgical were worth $2,571,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently made changes to their positions in ISRG. Bennett Selby Investments LP increased its position in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after purchasing an additional 17 shares in the last quarter. Onefund LLC increased its position in Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after purchasing an additional 18 shares in the last quarter. Wesbanco Bank Inc. grew its holdings in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after buying an additional 19 shares during the period. Journey Strategic Wealth LLC grew its holdings in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock valued at $542,000 after buying an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC grew its holdings in Intuitive Surgical by 3.7% in the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock valued at $275,000 after buying an additional 19 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded up $4.39 during mid-day trading on Wednesday, reaching $554.58. The stock had a trading volume of 368,299 shares, compared to its average volume of 2,041,817. Intuitive Surgical, Inc. has a fifty-two week low of $396.15 and a fifty-two week high of $616.00. The business's 50 day moving average is $513.67 and its 200 day moving average is $538.20. The stock has a market cap of $198.77 billion, a P/E ratio of 86.52, a PEG ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the company posted $1.50 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Erste Group Bank cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Evercore ISI reduced their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday, April 23rd. Truist Financial reduced their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Citigroup reaffirmed a "buy" rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Robert W. Baird cut their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average price target of $596.05.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 188 shares of the firm's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now owns 7,162 shares of the company's stock, valued at approximately $4,060,424.28. This trade represents a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 32,700 shares of company stock valued at $16,865,621. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.